NCT06369662Completed
CD155 Expression in Acute Myeloid Leukemia
Prognostic and Predictive Values of CD155 in Patients With Acute Myeloid Leukemia
Source: ClinicalTrials.gov · Last updated 16 Oct 2024
Brief summary (registry, in English)
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy. It is the most common form of acute leukemia among adults. In the United States, an estimated 19,940 people will be diagnosed with AML in 2020. CD155 expression was associated with an unfavorable prognosis in solid tumors such as colon cancer, breast cancer, lung adenocarcinoma, pancreatic cancer, melanoma, and glioblastoma, as it correlated with tumor migration, development of metastases, tissue and lymph node invasion, relapse, and poorer survival.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 93 (actual)
- First submitted
- 12 Jul 2021
- Start date
- 1 Jul 2022
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- Assiut University
- Diseases
- Acute myeloid leukemia
- NCT number
- NCT06369662
What you commit to
- Study type: Observational
- Participants enrolled: 93
- From 1 Jul 2022 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patients with concurrent malignancy.
Age
- Patients less than 18 years old and over 60 years.
Other
- Secondary AML.
- Acute Promyelocytic leukemia (AML-M3).
Who the study is looking for
- Patients with newly diagnosed AML.
- Age group: patients more than 18 years old and less than 60 years.
- Patients receiving induction chemotherapy 3\&7 at South Egypt Cancer Institute.
Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| South Egypt Cancer Institute - Assiut University Coordinator of this site? Confirm its status | Asyut | Egypt | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.